Page results
-
We are a specialist psychological team situated within the paediatric Audio-Vestibular Medical Services. We work psychologically with children, young people and their families who experience AVM conditions and also particular types of referrals, specifically tinnitus, hyperacusis and misophonia, from outside the hospital.
-
This page provides an overview of our Teenage and Young Adult (TYA) Ambulatory Care Service available to patients aged 12 to 24 years.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
A drop-in service providing support, practical advice and information.
-
Information about energy conservation for UCLH patients with mitochondrial disease.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
-
This service is unique in the UK, offering an adolescent rheumatology service that provides diagnostic and therapeutic advice to patients with any rheumatic diseases that occur in adolescence.
-
The children's FGM service is a dedicated monthly multidisciplinary clinic for girls under 18 years old who have had, are suspected to have had, or who may be at risk of having, FGM.
-
Paediatric Audio-vestibular Medicine provides investigation, diagnosis and management of the medical aspect of disorders of hearing, balance and tinnitus in children. The service consists of a multi-professional team and is located at The Royal National ENT & Eastman Dental Hospitals, 47-49 Huntley Street London WC1E 6DG.
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
File results
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data